N/A
Completed N=41
Pilot Study for a Prospective Surveillance Program for Rehabilitation Following Surgery for Breast Cancer
Source: ClinicalTrials.gov NCT02754427 ↗Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Number of Participants With Arm Morbidity at 12 Months Post-surgery - Shoulder Mobility — 5; 7 Participants
Summary
Breast cancer treatment often results in long-term arm morbidity. A prospective surveillance model with arm assessment pre-surgery followed by ongoing surveillance and targeted physiotherapy treatment after breast cancer surgery may improve early detection and management of arm morbidity. This study aims to determine the effect of prospective surveillance to target physiotherapy on the prevalence of arm morbidity in the surveillance group compared to control group at 12-months after breast cancer surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Arm Morbidity at 12 Months Post-surgery - Shoulder Mobility |
5; 7 | — |
| PRIMARY Number of Participants With Arm Morbidity at 12 Months Post-surgery - Upper Body Muscle Strength |
1; 4 | — |
| PRIMARY Number of Participants With Arm Morbidity at 12 Months Post-surgery - Upper Body Function |
5; 3 | — |
| PRIMARY Number of Participants With Arm Morbidity at 12 Months Post-surgery - Arm Volume |
0; 1 | — |
Eligibility Criteria
Inclusion Criteria
- age 30-75 years; receiving surgery for breast cancer, including those who will have immediate breast reconstruction.
Exclusion Criteria
- prior breast cancer surgery; a pre-existing shoulder pathology on the side of breast surgery that limits shoulder range of motion <75% of non-affected side; or a diagnosis of primary lymphedema
Data sourced from ClinicalTrials.gov (NCT02754427). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.